4//SEC Filing
GARDNER JASON 4
Accession 0000899243-22-037431
CIK 0001690585other
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 4:23 PM ET
Size
6.7 KB
Accession
0000899243-22-037431
Insider Transaction Report
Form 4
GARDNER JASON
DirectorSee Remarks
Transactions
- Award
Common Stock
2022-11-30$0.94/sh+3,000$2,820→ 292,872 total
Holdings
- 292,990(indirect: By Trust)
Common Stock
- 359,092(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Magenta Therapeutics, Inc. 2019 Employee Stock Purchase Plan (the "ESPP") for the ESPP purchase period of June 1, 2022 through November 30, 2022. This transaction is exempt under both Rule 16b-3(c) and Rule 16b-3(d).
- [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on June 1, 2022.
Documents
Issuer
Magenta Therapeutics, Inc.
CIK 0001690585
Entity typeother
Related Parties
1- filerCIK 0001741286
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 4:23 PM ET
- Size
- 6.7 KB